The vaccine cell (VC) that we will model here is similar to the latter one and consists of a HER-2/neu transgenic mammary carcinoma cell allogeneic with respect to the host and transduced with IL-12 genes. The gene discussed is ERBB2; the disease is breast carcinoma.